1
|
Toussi N, Daida K, Moser M, Le D, Hagel K, Kanthan R, Shaw J, Zaidi A, Chalchal H, Ahmed S. Prognostic Factors in Patients Diagnosed with Gallbladder Cancer over a Period of 20 Years: A Cohort Study. Cancers (Basel) 2024; 16:2932. [PMID: 39272789 PMCID: PMC11394600 DOI: 10.3390/cancers16172932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Revised: 08/19/2024] [Accepted: 08/22/2024] [Indexed: 09/15/2024] Open
Abstract
BACKGROUND Gallbladder cancer (GBC) is an uncommon cancer. This study aimed to determine the outcomes of GBC in relation to geographic, demographic, and clinical factors in a Canadian province from 2000 to 2019. METHODS This population-based retrospective cohort study included all patients diagnosed with gallbladder cancer (GBC) in Saskatchewan, Canada, from 2000 to 2019. Cox proportional multivariate regression analysis was conducted to identify factors associated with poorer outcomes. RESULTS In total, 331 patients with a median age of 74 years and male-female ratio of 1:2 were identified. Of these patients, 305 (92%) had a pathological diagnosis of GBC. Among patients with documented staging data, 64% had stage IV disease. A total of 217 (66%) patients were rural residents, and 149 (45%) were referred to a cancer center. The multivariate analysis for patients with stage I-III GBC showed that stage III disease [hazard ratio (HR), 2.63; 95% confidence interval (CI), 1.09-6.34)] and urban residence (HR, 2.20; 95% CI, 1.1-4.39) were correlated with inferior disease-free survival. For all patients, stage IV disease (HR, 3.02; 95% CI, 1.85-4.94), no referral to a cancer center (HR, 2.64; 95% CI, 1.51-4.62), lack of surgery (HR, 1.63; 95% CI, 1.03-2.57), a neutrophil-lymphocyte ratio of >3.2 (HR, 1.57; 1.05-2.36), and age of ≥70 years (HR, 1.51; 95% CI, 1.04-2.19) were correlated with inferior overall survival. CONCLUSIONS In this real-world context, the majority of patients with GBC were diagnosed at a late stage and were not referred to a cancer center. For those with early-stage GBC, living in an urban area and having stage III disease were linked to worse outcomes. Across all stages of GBC, stage IV disease, older age, absence of surgery, lack of referral to a cancer center, and a high neutrophil-to-lymphocyte ratio were associated with poorer survival.
Collapse
Affiliation(s)
- Nima Toussi
- College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
| | - Krishna Daida
- College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
| | - Michael Moser
- College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Department of Surgery, University of Saskatchewan, Saskatoon, SK S7N0W8, Canada
| | - Duc Le
- College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Department of Oncology, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Saskatoon Cancer Center, Saskatoon, SK S7N4H4, Canada
| | - Kimberly Hagel
- College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Department of Oncology, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Allan Blair Cancer Center, Regina, SK S4T7T1, Canada
| | - Rani Kanthan
- College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Canada Department of Pathology, University of Saskatchewan, Saskatoon, SK S7N0W8, Canada
| | - John Shaw
- College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Department of Surgery, University of Saskatchewan, Saskatoon, SK S7N0W8, Canada
| | - Adnan Zaidi
- College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Department of Oncology, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Saskatoon Cancer Center, Saskatoon, SK S7N4H4, Canada
| | - Haji Chalchal
- College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Department of Oncology, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Allan Blair Cancer Center, Regina, SK S4T7T1, Canada
| | - Shahid Ahmed
- College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Department of Oncology, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada
- Saskatoon Cancer Center, Saskatoon, SK S7N4H4, Canada
| |
Collapse
|
2
|
Singh D, Singh P, Mandal A, Rakesh A. Prognostic Insights and Survival Analysis of Gallbladder Cancer in Bihar, India: a Prospective Observational Study Emphasizing the Impact of Surgical Intervention on Overall Survival. Indian J Surg Oncol 2024; 15:196-203. [PMID: 38817991 PMCID: PMC11133252 DOI: 10.1007/s13193-024-01925-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2024] [Accepted: 03/11/2024] [Indexed: 06/01/2024] Open
Abstract
The aim of this study was to determine the 1- and 3-year overall survival rates. This prospective observational study was conducted at a tertiary care center in Bihar state, India. The study analyzed 228 patients in Bihar with a median age at diagnosis of 55 ± 12.05 years. The most common symptoms included upper abdominal pain (26.3%), weight loss (14%), and ascites (13.6%). The majority of patients presented at stage IV (72.8%), with liver metastasis being prevalent (61.4%). Interventional biliary drainage was performed in 9.6% of cases, and systemic chemotherapy was received by 84.64%, while 15.36% opted for best supportive care. Univariate Cox regression analysis identified Eastern Cooperative Oncology Group (ECOG) performance status, stage, gallstone disease, and surgical intervention as significant risk factors influencing overall survival (OS) (p < 0.001). Multivariate Cox regression analysis confirmed ECOG performance status (p < 0.001), stage (p = 0.039), and surgical intervention (p = 0.038) as independent factors impacting OS. One-year OS rates for stages II, III, and IV were 100%, 97%, and 44%, respectively, while 3-year OS rates were 29%, 4%, and 0%. Surgical intervention significantly influenced OS (p < 0.001). OS for surgical intervention was 28 months, and for inoperable cases, it was 12 months. One- and 3-year OS for surgical intervention were 95% and 11%, while for inoperable cases, they were 41% and 0%, respectively. Patients with gallbladder cancer, particularly in Bihar's Gangetic plains, face poor survival, especially with advanced disease. Adequate surgery improves outcomes, prompting a call for enhanced strategies, particularly for locally advanced GBC.
Collapse
Affiliation(s)
- Dharmendra Singh
- Department of Radiotherapy, All India Institute of Medical Sciences, Deoghar, Jharkhand India
| | - Pritanjali Singh
- Department of Radiotherapy, All India Institute of Medical Sciences, Patna, India
| | - Avik Mandal
- Department of Radiation Oncology, Medella Karkinos Oncology Institute, Kolkata, India
| | - Amrita Rakesh
- Department of Radiation Oncology, SAVERA Cancer and Multispeciality Hospital, Patna, India
| |
Collapse
|
3
|
Sharma S, Walia BS, Randhawa M, Sharma A, Dugg P, Pannu JS. Histopathological changes in gall bladder mucosa in relation to the number, and size of gallstones, and analysis of the findings in the context of age distribution of the patients: A perspective. Ann Hepatobiliary Pancreat Surg 2023; 27:277-286. [PMID: 37547937 PMCID: PMC10472125 DOI: 10.14701/ahbps.23-010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Revised: 04/02/2023] [Accepted: 04/05/2023] [Indexed: 08/08/2023] Open
Abstract
Backgrounds/Aims To study histopathological changes in gall bladder mucosa in cholelithiasis patients, and analyse their relation to the number and size of gallstones. These findings were evaluated in the context of age distribution of the study population. Methods One hundred cases of cholecystectomy were part of the study, which was conducted in collaboration with the pathology department. The time period of the study was January 2020 to June 2021. Results Maximum cases had multiple stones (69.0%), while one third cases (31.0%) had solitary stones. While initial univariate analysis showed age (odds ratio [OR], 6.882; p = 0.043), gallstone number (OR, 9.1; p = 0.050), gallstone size (OR, 17.111; p = 0.013), and duration of symptom (OR, 34.125; p = 0.001) to be significant risk factors associated with gallbladder carcinoma, multivariate analysis found none of these variables to be significant. However, conditional multivariate analysis for the duration of symptom (p = 0.008; OR, 21.118) yielded significant p- value. With histopathological diagnoses, 5% of cases had gallbladder cancer. Conclusions This study shed light on the rising incidence of cholelithiasis in the young population and the high rate of gallbladder carcinoma in Punjab, India. Although gall stone characteristics (size, number) and patient age appeared to be significant risk factors when their individual relation with gallbladder carcinoma was studied, multivariate analysis, could not prove that. Conditional multivariate analysis showed the duration of symptom to be the only significant risk factor associated with gallbladder carcinoma. Further research with larger sample size is needed to study the rising incidence of gallbladder carcinoma, and the risk factors associated with it.
Collapse
Affiliation(s)
- Sanjeev Sharma
- Department of Surgery, Government Medical College, Amritsar, India
| | | | - Mandeep Randhawa
- Department of Pathology, Government Medical College, Amritsar, India
| | - Arjun Sharma
- Department of Surgery, Government Medical College, Amritsar, India
| | - Pankaj Dugg
- Department of Surgery, Government Medical College, Amritsar, India
| | | |
Collapse
|
4
|
Dutta A, Mungle T, Chowdhury N, Banerjee P, Gehani A, Sen S, Mallath M, Roy P, Krishnan S, Ganguly S, Banerjee S, Roy M, Saha V. Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017-2019. Cancer Med 2023; 12:9293-9302. [PMID: 36779618 PMCID: PMC10166897 DOI: 10.1002/cam4.5677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2022] [Revised: 01/18/2023] [Accepted: 01/28/2023] [Indexed: 02/14/2023] Open
Abstract
BACKGROUND The north and north-eastern regions of India have among the highest incidence of gallbladder cancer (GBC) in the world. We report the clinicopathological charateristics and outcome of GBC patients in India. METHODS Electronic medical records of patients diagnosed with GBC at Tata Medical Center, Kolkata between 2017 and 2019 were analyzed. RESULTS There were 698 cases of confirmed GBC with a median age of 58 (IQR: 50-65) years and female:male ratio of 1.96. At presentation, 91% (496/544) had stage III/IV disease and 30% (189/640) had incidental GBC. The 2-year overall survival (OS) was 100% (95% CI: 100-100); 61% (95% CI: 45-83); 30% (95% CI: 21-43); and 9% (95% CI: 6-13) for stages I-IV, respectively (p = <0.0001). For all patients, the 2-year OS in patients who had a radical cholecystectomy followed by adjuvant therapy (N = 36) was 50% (95% CI: 39-64), compared to 29% (95% CI: 22-38) for those who had a simple cholecystectomy and/or chemotherapy (N = 265) and 9% (95% CI: 6-14) in patients who were palliated (N = 107) (p = <0.0001). CONCLUSION The combined surgical/chemotherapy approach for patients with stage II GBC showed the best outcomes. Early detection of GBC remains problematic with the majority of patients presenting with stage III-IV and who have a median survival of 9.1 months. Our data suggests that the tumor is chemoresponsive and multi-center collaborative clinical trials to identify alternative therapies are urgently required.
Collapse
Affiliation(s)
- Anindita Dutta
- Cell Biology, Tata Translational Cancer Research Centre, Kolkata, India.,Division of Cancer Sciences, University of Manchester, Manchester, UK
| | - Tushar Mungle
- Clinical Research Unit, Tata Translational Cancer Research Centre, Kolkata, India
| | - Nandita Chowdhury
- Cell Biology, Tata Translational Cancer Research Centre, Kolkata, India
| | - Pritha Banerjee
- Clinical Research Unit, Tata Translational Cancer Research Centre, Kolkata, India
| | - Anisha Gehani
- Department of Radiology, Tata Medical Center, Kolkata, India
| | - Saugata Sen
- Department of Radiology, Tata Medical Center, Kolkata, India
| | - Mohandas Mallath
- Department of Digestive Diseases, Tata Medical Center, Kolkata, India
| | - Paromita Roy
- Department of Histopathology, Tata Medical Center, Kolkata, India
| | - Shekhar Krishnan
- Division of Cancer Sciences, University of Manchester, Manchester, UK.,Clinical Research Unit, Tata Translational Cancer Research Centre, Kolkata, India.,Department of Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, India
| | - Sandip Ganguly
- Department of Medical Oncology, Tata Medical Center, Kolkata, India
| | - Sudeep Banerjee
- Department of Gastrointestinal and Hepatobiliary Surgery, Tata Medical Center, Kolkata, India
| | - Manas Roy
- Department of Gastrointestinal and Hepatobiliary Surgery, Tata Medical Center, Kolkata, India
| | - Vaskar Saha
- Cell Biology, Tata Translational Cancer Research Centre, Kolkata, India.,Division of Cancer Sciences, University of Manchester, Manchester, UK.,Department of Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, India
| |
Collapse
|